New Law To Eliminate Deceptive MA Comparisons to Protect Vulnerable Seniors
Congressional bill aims to improve Medicare Advantage comparisons by using accurate data and transparent methods, ensuring fair Medicare policy for seniors and taxpayers.
Congressional bill aims to improve Medicare Advantage comparisons by using accurate data and transparent methods, ensuring fair Medicare policy for seniors and taxpayers.
California is advancing a bill to regulate car dealer fees, banning junk fees, requiring full price transparency, and establishing a used car return period. This follows previous federal efforts and could reshape auto retail practices.
Congress returns to negotiate FY 2026 government funding with a deadline on Sept 30, facing bipartisan challenges and potential shutdown.
ACA health insurance premiums are set to rise sharply in 2026 as enhanced premium subsidies expire, with insurers citing medical inflation and drug costs. Congressional action is uncertain amid strong public support for subsidy extension.
Iowa Senator Chuck Grassley outlines Medicaid funding changes under the Big Beautiful Bill, Medicare reimbursement challenges, and bipartisan legislative efforts impacting healthcare and education policy in Iowa.
Colorado lawmakers propose pausing the wolf reintroduction program to reallocate funds towards health insurance subsidies amid budget challenges and rising insurance premiums.
Analysis of Barack Obama's presidency focusing on legislative challenges, political strategy, and impacts on U.S. policy and legacy.
Senator Kelly outlines significant effects of recent Medicaid and Social Security policy changes in Arizona, focusing on coverage loss, work requirements, and bipartisan legislative efforts.
The recent Republican tax legislation will trigger automatic Medicare payment cuts starting in 2026 due to sequestration mandated by the Budget Control Act, impacting provider reimbursements through 2034.
Medicare faces evolving opportunities and challenges in covering weight loss drugs through legislation like the Treat and Reduce Obesity Act and federal demonstration projects. Drug adherence and cost-effectiveness remain key issues.